These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28435994)

  • 21. New strategies in the treatment of the thalassemias.
    Schrier SL; Angelucci E
    Annu Rev Med; 2005; 56():157-71. PubMed ID: 15660507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on thalassemia treatment in Taiwan, including bone marrow transplantation, chelation therapy, and cardiomyopathy treatment effects.
    Peng CT; Chang JS; Wang LY; Chiou SS; Hsiao CC; Wang SC; Hung GY; Wu KH
    Hemoglobin; 2009; 33(5):304-11. PubMed ID: 19814676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major children.
    Abu Samra O; Auda W; Kamhawy H; Al-Tonbary Y
    Hematology; 2015 Jun; 20(5):297-303. PubMed ID: 25181014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalassemia: Common Clinical Queries in Management.
    Lal A; Bansal D
    Indian J Pediatr; 2020 Jan; 87(1):75-81. PubMed ID: 31620986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current trends in the management of beta thalassemia.
    Dubey AP; Parakh A; Dublish S
    Indian J Pediatr; 2008 Jul; 75(7):739-43. PubMed ID: 18716746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta-thalassemia major in children and adolescents in Denmark].
    Jung A; Main KM; Scheibel E; Peitersen B; Clausen N; Erichsen G; Schmiegelow K; Illum N
    Ugeskr Laeger; 2002 Dec; 164(49):5803-6. PubMed ID: 12523224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalassemia Major: Transplantation or Transfusion and Chelation.
    Mohamed SY
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):290-298. PubMed ID: 28651066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical management of beta-thalassaemia without blood transfusion: a myth or a reality?
    Shamsi T; Ansari S
    J Pak Med Assoc; 2013 Mar; 63(3):304-5. PubMed ID: 23914624
    [No Abstract]   [Full Text] [Related]  

  • 29. Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia.
    Tsironi M; Polonifi K; Deftereos S; Farmakis D; Andriopoulos P; Moyssakis I; Aessopos A
    Eur J Haematol; 2005 Oct; 75(4):355-8. PubMed ID: 16146544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy.
    Lucarelli G; Galimberti M; Polchi P; Angelucci E; Baronciani D; Giardini C; Andreani M; Agostinelli F; Albertini F; Clift RA
    N Engl J Med; 1993 Sep; 329(12):840-4. PubMed ID: 8355742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures.
    Javanbakht M; Keshtkaran A; Shabaninejad H; Karami H; Zakerinia M; Delavari S
    Int J Health Policy Manag; 2015 Jun; 4(11):733-40. PubMed ID: 26673333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Beta-thalassemia: clinical manifestations].
    Perrimond H
    Bull Soc Pathol Exot; 2001 May; 94(2):92-4. PubMed ID: 11475035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital sideroblastic anemia treated as thalassemia major.
    Chowdhury RK; Miah MZ; Morshed M
    Mymensingh Med J; 2010 Oct; 19(4):636-9. PubMed ID: 20956913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone marrow transplantation in thalassemia].
    Lukarelli G; Galimberti M; Pol'ki P; Andzheluchchi E; Baronchiani D; Dzhardini K; Duratstsi S; Agostinelli F; Dzhordzhi K; Donati M
    Gematol Transfuziol; 1993; 38(8):7-11. PubMed ID: 8307317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current approach to iron chelation in children.
    Aydinok Y; Kattamis A; Viprakasit V
    Br J Haematol; 2014 Jun; 165(6):745-55. PubMed ID: 24646011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of a triple alpha-globin gene with beta-thalassemia in a gypsy family: importance of the genetic testing in the diagnosis and search for a donor for bone marrow transplantation for one of their children.
    Yus Cebrian F; Recasens Flores Mdel V; Izquierdo Álvarez S; Parra Salinas I; Rodriguez-Vigil Iturrate C
    BMC Res Notes; 2016 Apr; 9():220. PubMed ID: 27080228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary Functions in Children With Thalassemia Major.
    Ozyoruk D; Misirlioglu ED
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):605-10. PubMed ID: 26422288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease.
    Marsella M; Borgna-Pignatti C
    Hematol Oncol Clin North Am; 2014 Aug; 28(4):703-27, vi. PubMed ID: 25064709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.